Trial Profile
Clinical Trials Insight: 700008661
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2005
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial occlusive disorders; Restenosis
- Focus Therapeutic Use
- 22 Nov 2005 New trial record.